LLY - ELI LILLY & Co
734.57
-16.880 -2.298%
Share volume: 4,072,561
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$751.45
-16.88
-0.02%
Summary score
69%
Profitability
75%
Dept financing
25%
Liquidity
54%
Performance
77%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
18.71%
Return on assets
3.4%
Return on sales
24.27%
Return on invested capital
5.38%
Total debt ratio
78.91%
Debt ratio change over timeo
0%
Current Ratio
1.34%
Quick Ratio
1.02%
Cash Position Ratio
0.33%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
41.05%
Return on assets
3.67%
Return on sales
26.16%
Return on invested capital
9.43%
Total debt ratio
91.28%
Debt ratio change over timeo
0%
Current Ratio
1.21%
Quick Ratio
0.94%
Cash Position Ratio
0.21%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
25.03%
Return on assets
3.14%
Return on sales
24.03%
Return on invested capital
7.68%
Total debt ratio
89.02%
Debt ratio change over time
0%
Current Ratio
1.36%
Quick Ratio
1.06%
Cash Position Ratio
0.3%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LLY | JNJ | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 18.71% | 4.67% | 19.62% | 0% |
| Return on assets | 3.4% | 3.32% | 11.24% | 0% |
| Return on sales | 24.27% | 25.81% | 41.89% | 0% |
| Return on invested capital | 5.38% | 4.17% | -280.52% | 0% |
| Profitability | 71% | 48% | 75% | 0% |
| Total debt ratio | 78.91% | 58.54% | 54.01% | 0% |
| Debt ratio change over time | 0% | 10.69% | 0% | 0% |
| Dept financing | 25% | 44% | 17% | 0% |
| Current Ratio | 1.21% | 1.33% | 1.08% | 0% |
| Quick Ratio | 0.94% | 1.07% | 0.79% | 0% |
| Cash Position Ratio | 0.21% | 0.6% | 0.32% | 0% |
| Liquididy | 56% | 75% | 48% | 0% |
| Short-term ratios | LLY | JNJ | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 41.05% | 6.87% | 16.13% | 0% |
| Return on assets | 3.67% | 3.13% | 8.75% | 0% |
| Return on sales | 26.16% | 24.75% | 38.84% | 0% |
| Return on invested capital | 9.43% | 5.58% | -6.74% | 0% |
| Profitability | 77% | 44% | 60% | 0% |
| Total debt ratio | 91.28% | 61.3% | 55.02% | 0% |
| Debt ratio change over time | 0% | 13.89% | 0% | 0% |
| Dept financing | 25% | 42% | 15% | 0% |
| Current Ratio | 1.21% | 1.33% | 1.08% | 0% |
| Quick Ratio | 0.94% | 1.07% | 0.79% | 0% |
| Cash Position Ratio | 0.21% | 0.6% | 0.32% | 0% |
| Liquididy | 53% | 75% | 52% | 0% |
